Filter By:

New checkpoint inhibitor shows promise in clinical trial for non-Hodgkin’s lymphoma

A novel antibody plus rituximab can block the “don’t eat me” signal, enabling macrophages to devour cancer cells.

Dreams do come true after advanced care for lymphoma
Immunotherapy: Why don't more patients respond?